Leeann Reed
Physician Assistant · Athens, OHNPI 1114279478
Payments from drug & device makers
Across 235 payments — averaging $15.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$990
- Otsuka America Pharmaceutical, Inc.$532
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$433
- Johnson & Johnson$334
- Lundbeck LLC$258
- Corium, LLC$186
- plus $978 from 10 others
What the payments were for
- Food & beverage$3,66299%
- Education$491%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 86 | $990 |
| Otsuka America Pharmaceutical, Inc. | 29 | $532 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 25 | $433 |
| Johnson & Johnson | 17 | $334 |
| Lundbeck LLC | 15 | $258 |
| Corium, LLC | 11 | $186 |
| Sunovion Pharmaceuticals Inc. | 12 | $166 |
| Neurocrine Biosciences, Inc. | 8 | $157 |
| Vanda Pharmaceuticals Inc. | 5 | $145 |
| Teva Pharmaceuticals USA, Inc. | 7 | $107 |
| Alkermes, Inc. | 5 | $101 |
| E.r. Squibb & Sons, L.L.C. | 4 | $96 |
| Axsome Therapeutics, Inc. | 4 | $80 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $75 |
| Ironshore Pharmaceuticals Inc. | 2 | $39 |
| Novo Nordisk | 1 | $13 |
How this compares
$3,711 in reported general payments places this provider in the 90th percentile of 4,098 physician assistant providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 69 | $105,922 |
| RexultiBrexpiprazole | 43 | $70,965 |
| Abilify MaintenaAripiprazole | 21 | $58,096 |
| Invega SustennaPaliperidone Palmitate | 27 | $57,971 |
| Lurasidone Hcl | 50 | $16,641 |
| TrintellixVortioxetine Hydrobromide | 17 | $10,333 |
| Oxcarbazepine | 106 | $3,705 |
| Clozapine | 24 | $3,175 |
| Duloxetine Hcl | 238 | $2,978 |
| Quetiapine Fumarate | 132 | $2,906 |
| Vilazodone Hcl | 17 | $2,558 |
| Ziprasidone Hcl | 69 | $2,429 |
| Buspirone Hcl | 233 | $2,169 |
| Perphenazine | 19 | $2,052 |
| Aripiprazole | 78 | $1,965 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Otsuka America Pharmaceutical, Inc.Rexulti, Abilify Maintena | $532 | $129,06264 claims |
| AbbVieVraylar | $990 | $105,92269 claims |
| Johnson & JohnsonInvega Sustenna | $334 | $57,97127 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $75 | $10,33317 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,098 physician assistant providers in Ohio.
Other physician assistant in Athens
- Adriana WalshAthens$15K
- Steven WurzelbacherCincinnati$309K
- Emily AnkromDayton$192K
- Amanda MaggartWorthington$164K
- Megan SevillaMayfield Heights$132K
- Erin StrculaBelpre$106K
- Natalie WalkupSylvania$105K
- Sarah LaubNew Albany$100K
- Jessica RhominskiCanal Winchester$78K
- Alan OdonnellCincinnati$71K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.